Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruo Sugiyama

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Hematology|September 7, 2002
Cancer immunotherapy targeting WT1 proteinHaruo Sugiyama
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 23, 2004
[Development of a new inspection diagnostic method: genetic screening of cancer]Haruo Sugiyama
Blood|September 24, 2008
Expectation for DNA leukemia vaccinesHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[WT1-targeting cancer vaccine]Haruo Sugiyama
Current Opinion in Immunology|June 6, 2008
Tumor immunology. Editorial overviewHaruo Sugiyama
Japanese Journal of Clinical Oncology|April 17, 2010
WT1 (Wilms' tumor gene 1): biology and cancer immunotherapyHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2005
[WT1 peptide-based immunotherapy]Haruo Sugiyama
Methods in Molecular Medicine|March 21, 2002
Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesisHaruo Sugiyama
Expert Review of Vaccines|August 25, 2005
Cancer immunotherapy targeting Wilms' tumor gene WT1 productHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
WT1 peptide cancer vaccineHaruo Sugiyama
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Hematology|September 7, 2002
Cancer immunotherapy targeting WT1 proteinHaruo Sugiyama
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 23, 2004
[Development of a new inspection diagnostic method: genetic screening of cancer]Haruo Sugiyama
Blood|September 24, 2008
Expectation for DNA leukemia vaccinesHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[WT1-targeting cancer vaccine]Haruo Sugiyama
Current Opinion in Immunology|June 6, 2008
Tumor immunology. Editorial overviewHaruo Sugiyama
Japanese Journal of Clinical Oncology|April 17, 2010
WT1 (Wilms' tumor gene 1): biology and cancer immunotherapyHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2005
[WT1 peptide-based immunotherapy]Haruo Sugiyama
Methods in Molecular Medicine|March 21, 2002
Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesisHaruo Sugiyama
Expert Review of Vaccines|August 25, 2005
Cancer immunotherapy targeting Wilms' tumor gene WT1 productHaruo Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
WT1 peptide cancer vaccineHaruo Sugiyama
Pageof 21